Patient prognostic scores and association with survival improvement offered by postoperative radiotherapy for resected IIIA/N2 non‐small cell lung cancer: A population‐based study

BACKGROUND: Currently, there is no consensus on the role of postoperative adjuvant radiotherapy (PORT) for resected stage IIIA/N2 non‐small cell lung cancer (NSCLC). Our study sought to determine which patients may be able to benefit from PORT, based on a patient prognostic score. METHODS: A retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lei, Xie, Hou‐nai, Chen, Xian‐kai, Bi, Nan, Qin, Jian‐jun, Li, Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952782/
https://www.ncbi.nlm.nih.gov/pubmed/33481353
http://dx.doi.org/10.1111/1759-7714.13835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952782/
https://www.ncbi.nlm.nih.gov/pubmed/33481353
http://dx.doi.org/10.1111/1759-7714.13835

Ejemplares similares